Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Glioblastoma × marizomib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Radiotherapy 15 Temozolomide 13 Carmustine 6 Lomustine 3 Bevacizumab 3 imetelstat 2 Radiosurgery 2 Radiation 2 Immunohistochemistry 2 Everolimus 2 DNA Methylation 2 Chemotherapy, Adjuvant 2 vistusertib 1 veliparib 1 vatalanib 1 temsirolimus 1 sagopilone 1 rubitecan 1 palbociclib 1 marizomib 1 fluciclovine F-18 1 carmustine, poliferprosan 20 drug combination 1 beta-D-glucosylisophosphoramide mustard 1 azurin (50-77) 1 Tamoxifen 1 Re-Irradiation 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Proton Therapy 1 Perfusion Magnetic Resonance Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03345095 2025-07-01

MIRAGE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed

749 enrolled 15 charts

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡